USS Investment Management Ltd continued to hold its position in Clorox Company (The) (NYSE:CLX) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 46,900 shares of the company’s stock at the end of the second quarter. USS Investment Management Ltd’s holdings in Clorox Company (The) were worth $6,250,000 as of its most recent SEC filing.
A number of other institutional investors have also recently added to or reduced their stakes in the stock. Crossvault Capital Management LLC raised its position in Clorox Company (The) by 3.8% in the first quarter. Crossvault Capital Management LLC now owns 34,684 shares of the company’s stock valued at $4,676,000 after buying an additional 1,285 shares during the last quarter. Ameriprise Financial Inc. raised its position in Clorox Company (The) by 2.4% in the first quarter. Ameriprise Financial Inc. now owns 1,076,072 shares of the company’s stock valued at $146,932,000 after buying an additional 25,110 shares during the last quarter. Geode Capital Management LLC raised its position in Clorox Company (The) by 4.3% in the first quarter. Geode Capital Management LLC now owns 1,247,940 shares of the company’s stock valued at $168,019,000 after buying an additional 51,563 shares during the last quarter. Destination Wealth Management raised its position in Clorox Company (The) by 14.0% in the first quarter. Destination Wealth Management now owns 30,225 shares of the company’s stock valued at $4,075,000 after buying an additional 3,716 shares during the last quarter. Finally, Janney Capital Management LLC bought a new position in shares of Clorox Company (The) during the first quarter valued at $216,000. Institutional investors and hedge funds own 69.83% of the company’s stock.
Shares of Clorox Company (NYSE:CLX) opened at 137.48 on Friday. Clorox Company has a 52-week low of $111.24 and a 52-week high of $141.76. The company has a market capitalization of $17.74 billion, a P/E ratio of 25.77 and a beta of 0.40. The stock’s 50 day moving average is $134.18 and its 200 day moving average is $134.70.
Clorox Company (The) (NYSE:CLX) last released its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.49 by $0.04. The business had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.65 billion. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The company’s quarterly revenue was up 2.9% on a year-over-year basis. During the same period in the prior year, the firm posted $1.30 earnings per share. Equities analysts expect that Clorox Company will post $5.67 EPS for the current year.
Several equities analysts have recently weighed in on CLX shares. Zacks Investment Research upgraded shares of Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 price objective on the stock in a report on Tuesday, July 4th. BMO Capital Markets reiterated a “buy” rating and set a $136.00 price objective on shares of Clorox Company (The) in a report on Thursday, May 4th. Barclays PLC reiterated an “equal weight” rating and set a $136.00 price objective (down previously from $140.00) on shares of Clorox Company (The) in a report on Friday, August 4th. Deutsche Bank AG reiterated a “hold” rating and set a $137.00 price objective (up previously from $126.00) on shares of Clorox Company (The) in a report on Saturday, July 22nd. Finally, Jefferies Group LLC set a $138.00 price objective on shares of Clorox Company (The) and gave the company a “hold” rating in a report on Wednesday, May 3rd. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $129.05.
In related news, EVP James E. Foster sold 9,861 shares of the stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $138.51, for a total value of $1,365,847.11. Following the completion of the transaction, the executive vice president now directly owns 22,069 shares of the company’s stock, valued at approximately $3,056,777.19. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Jon M. Balousek sold 9,223 shares of the stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $138.87, for a total transaction of $1,280,798.01. Following the completion of the transaction, the senior vice president now directly owns 20,614 shares of the company’s stock, valued at $2,862,666.18. The disclosure for this sale can be found here. Corporate insiders own 0.74% of the company’s stock.
Clorox Company (The) Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.
